About Manas AI
Manas AI is an AI-native biopharmaceutical company that combines neuro-symbolic, science-based foundation models and generative computational chemistry to discover and develop transformative medicines, starting with cancer and rare diseases. Its full-stack platform uses proprietary AI, generative computational chemistry, and advanced biology to accelerate drug development from target identification through clinical pipeline, with an initial focus on oncology (triple-negative breast cancer, prostate cancer, and lymphoma).
Company details
Funding
Total raised
$50.6M
Last stage
Seed
Investors
Founders
Siddhartha Mukherjee
Pulitzer Prize-winning oncologist, researcher, and author of 'The Emperor of All Maladies'. Leads Manas AI as CEO.
LinkedInUjjwal Singh
Seasoned technology executive; previously Chief Technology and Product Officer at Multiverse, Head of Workplace at Meta, and Senior Director of Engineering at Google.
LinkedIn
Reid Hoffman
Co-founder of LinkedIn and partner at Greylock. Renowned entrepreneur and technology investor. Also co-founded Inflection AI.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.